BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 20837822)

  • 21. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.
    Mosconi L; Brys M; Switalski R; Mistur R; Glodzik L; Pirraglia E; Tsui W; De Santi S; de Leon MJ
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19067-72. PubMed ID: 18003925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.
    Roberts RO; Knopman DS; Cha RH; Mielke MM; Pankratz VS; Boeve BF; Kantarci K; Geda YE; Jack CR; Petersen RC; Lowe VJ
    J Nucl Med; 2014 May; 55(5):759-64. PubMed ID: 24652830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
    Anchisi D; Borroni B; Franceschi M; Kerrouche N; Kalbe E; Beuthien-Beumann B; Cappa S; Lenz O; Ludecke S; Marcone A; Mielke R; Ortelli P; Padovani A; Pelati O; Pupi A; Scarpini E; Weisenbach S; Herholz K; Salmon E; Holthoff V; Sorbi S; Fazio F; Perani D
    Arch Neurol; 2005 Nov; 62(11):1728-33. PubMed ID: 16286547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin.
    Morris JK; Vidoni ED; Mahnken JD; Montgomery RN; Johnson DK; Thyfault JP; Burns JM
    Neurobiol Aging; 2016 Mar; 39():19-24. PubMed ID: 26923398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.
    Mosconi L; Mistur R; Switalski R; Tsui WH; Glodzik L; Li Y; Pirraglia E; De Santi S; Reisberg B; Wisniewski T; de Leon MJ
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):811-22. PubMed ID: 19142633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity.
    Marchitelli R; Aiello M; Cachia A; Quarantelli M; Cavaliere C; Postiglione A; Tedeschi G; Montella P; Milan G; Salvatore M; Salvatore E; Baron JC; Pappatà S
    Neuroimage; 2018 Aug; 176():246-258. PubMed ID: 29709628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-specific association between basal blood insulin and cerebral glucose metabolism in older adults.
    Byun MS; Kim HJ; Yi D; Choi HJ; Baek H; Lee JH; Choe YM; Lee SH; Ko K; Sohn BK; Lee JY; Lee Y; Kim YK; Lee YS; Lee DY;
    Neuroimage Clin; 2019; 22():101765. PubMed ID: 30904824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
    Bohnen NI; Koeppe RA; Minoshima S; Giordani B; Albin RL; Frey KA; Kuhl DE
    J Nucl Med; 2011 Jun; 52(6):848-55. PubMed ID: 21571793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered features of body composition in older adults with type 2 diabetes and prediabetes compared with matched controls.
    Bell KE; Paris MT; Avrutin E; Mourtzakis M
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1087-1099. PubMed ID: 35174664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.
    McLimans KE; Willette AA;
    J Alzheimers Dis; 2017; 56(1):403-413. PubMed ID: 27911319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition.
    Baghel V; Tripathi M; Parida G; Gupta R; Yadav S; Kumar P; Dey AB; Damle NA; Kumar R; Bal C
    Clin Nucl Med; 2019 Nov; 44(11):e597-e601. PubMed ID: 31584490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.
    Ossenkoppele R; van der Flier WM; Zwan MD; Adriaanse SF; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van Berckel BN
    Neurology; 2013 Jan; 80(4):359-65. PubMed ID: 23255822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading.
    Ishibashi K; Wagatsuma K; Ishiwata K; Ishii K
    Hum Brain Mapp; 2016 Aug; 37(8):2823-32. PubMed ID: 27061859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
    Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.